TrialBMC pediatrics2025

Combined impact of rituximab and target care on efficacy, quality of life, adverse reactions and recurrence rate in children with nephrotic syndrome: a randomized controlled trial.

Lanfen He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.